Related Experiment Video

Updated: Jul 10, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Gemcitabine plus carboplatin compared with carboplatin alone for platinum-sensitive recurrent ovarian cancer

Robert L Coleman

    Current Oncology Reports
    |November 10, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
    07:54

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

    Published on: October 25, 2011

    Related Experiment Videos

    Last Updated: Jul 10, 2026

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
    07:54

    Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

    Published on: October 25, 2011

    Related Concept Videos

    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial.

    The Lancet. Oncology·2026

    Endometrial Cancer by ERBB2 Amplification (ERBB2amp) Status: Differences in Molecular Subtypes, Ancestry, and Real-World Outcomes.

    JCO precision oncology·2026

    Poly(adenosine diphosphate-ribose) polymerase inhibitor maintenance therapy with niraparib in patients with primary advanced or recurrent endometrial cancer receiving dostarlimab plus chemotherapy.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

    Joint GOG-Foundation (GOG) and European Network of Gynaecological Oncological Trial Groups (ENGOT) clinical trials guidance for operations with industry partners.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

    Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trial.

    Gynecologic oncology·2026

    Efficacy translation between phase II and phase III trials in gynecologic oncology: a cross-phase meta-comparative analysis.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

    The Impact of Cancer Treatment On Oral Structures and the Facial Part of the Skull - Implications for Prosthetic Treatment and Oncological Risk.

    Current oncology reports·2026

    Next-Generation Sequencing in Translational Sarcoma Research: Biological Insights and Emerging Directions.

    Current oncology reports·2026

    What are the Unmet Needs in Managing Digestive Neuroendocrine Carcinomas?

    Current oncology reports·2026

    Recent Advances in Surveillance Strategies for Nasopharyngeal Carcinoma.

    Current oncology reports·2026

    Gender, Sex and Other Factors in the Development of Neuroendocrine Neoplasms.

    Current oncology reports·2026

    The Oral Microbiome in Oral Cavity Cancer: Mechanisms of Carcinogenesis, Biomarkers, and Therapeutic Implications.

    Current oncology reports·2026

    Efficacy and safety of the CAPTEM regimen in patients with advanced adrenocortical carcinoma.

    Endocrine connections·2026

    Dual-Pronged Light-Free Photodynamic Immunotherapy Enabled by a Chemiexcited Hydrogel.

    Small (Weinheim an der Bergstrasse, Germany)·2026

    Role of Chest Wall Perforator Flaps in Breast Surgery: Military Cancer Centre Experience.

    European journal of breast health·2026

    A novel human Streptomyces strain redresses malignancy by inducing apoptosis and regaining gut homeostasis.

    mSystems·2026

    Effect of Surgical Delay After Neoadjuvant Chemotherapy on Survival Outcomes in Breast Cancer: A Systematic Review and Meta-Analysis.

    European journal of breast health·2026

    Concomitant chemoradiotherapy for head and neck squamous cell carcinoma: Real-world treatment delivery, toxicity, and survival in Bosnia and Herzegovina.

    Biomolecules & biomedicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us